M
FOLD

Murchinson’s Amicus Therapeutics FOLD Stock Holding History

Murchinson’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16,700
Closed -$241K – 136
2026
Q1 		$241K Buy
+16,700
New +$239K 0.03% 71

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Murchinson's FOLD Position: Q2 2026 in Review

Murchinson sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 16,700 shares — an estimated $241K sold.

Murchinson first reported a position in FOLD in Q1 2026 and held it in 1 quarter. The position peaked at $241K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • Murchinson reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Murchinson sold 16,700 Amicus Therapeutics shares in Q2 2026, an estimated $241K.
  • Murchinson first reported a position in Amicus Therapeutics in Q1 2026 and held it in 1 quarter.
  • Murchinson's Amicus Therapeutics position peaked at $241K in Q1 2026.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Murchinson's 13F filing for Q2 2026, filed 14 Aug 2026.